Holen Sie sich die Stockscreener-App
69.17
0.89%
0.6174
Schlusskurs vom Vortag:
$68.55
Offen:
$68.96
24-Stunden-Volumen:
7.98M
Relative Volume:
0.57
Marktkapitalisierung:
$102.63B
Einnahmen:
$20.08B
Nettoeinkommen (Verlust:
$2.89B
KGV:
35.67
EPS:
1.9391
Netto-Cashflow:
$3.66B
1W Leistung:
-3.07%
1M Leistung:
-7.46%
6M Leistung:
-32.67%
1J Leistung:
-27.48%
1-Tages-Spanne:
$68.41
$69.59
1-Wochen-Bereich:
$67.56
$72.37
52-Wochen-Spanne:
$67.56
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
69.16 | 101.72B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
ABT
Abbott Laboratories
|
108.28 | 187.91B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
338.11 | 129.05B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.29 | 112.19B | 35.48B | 4.64B | 5.41B | 3.582 |
|
EW
Edwards Lifesciences Corp
|
81.94 | 49.14B | 6.07B | 1.06B | 1.34B | 1.8063 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-03 | Herabstufung | Erste Group | Buy → Hold |
| 2025-09-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
INVESTOR NOTICE: Boston Scientific Corporation Investors with Su - GuruFocus
Boston Scientific stock hits 52-week low at 68.19 USD - Investing.com
INVESTOR NOTICE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
BSX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 – Company AnnouncementFT.com - Financial Times
Boston Scientific Corp (NYSE:BSX): A GARP Stock with Strong Growth and Reasonable Valuation - ChartMill
Franklin Resources Inc. Sells 708,747 Shares of Boston Scientific Corporation $BSX - MarketBeat
First Trust Advisors LP Boosts Stock Position in Boston Scientific Corporation $BSX - MarketBeat
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - Financial Times
Deadline Approaching: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith - ChartMill
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Kepler Cheuvreux Suisse SA Buys Shares of 276,126 Boston Scientific Corporation $BSX - MarketBeat
Mackenzie Financial Corp Increases Position in Boston Scientific Corporation $BSX - MarketBeat
Magnetar Financial LLC Has $6.78 Million Holdings in Boston Scientific Corporation $BSX - MarketBeat
Citigroup Adjusts Price Target on Boston Scientific to $94 From $102, Maintains Buy Rating - marketscreener.com
Baird Adjusts Price Target on Boston Scientific to $95 From $101, Maintains Outperform Rating - marketscreener.com
Capital Research Global Investors Acquires 23,940 Shares of Boston Scientific Corporation $BSX - MarketBeat
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
INVESTOR ALERT: Boston Scientific Corporation Investors - GlobeNewswire
BSX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
BSX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 (2026-03-10) - Seeking Alpha
Important Notice to Long-Term Shareholders of Boston - GlobeNewswire
Class Action Filed Against Boston Scientific Corporation (BSX)May 4, 2026 Deadline to JoinContact The Gross Law Firm - marketscreener.com
Richard Bernstein Advisors LLC Sells 51,186 Shares of Boston Scientific Corporation $BSX - MarketBeat
Capital World Investors Has $2.60 Billion Holdings in Boston Scientific Corporation $BSX - MarketBeat
2026-03-10 | BSX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NYSE:BSX | Press Release - Stockhouse
Swiss National Bank Has $416.36 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Stake Lowered by Schroder Investment Management Group - MarketBeat
Fieldview Capital Management LLC Invests $5.34 Million in Boston Scientific Corporation $BSX - MarketBeat
BSX Investors Have Opportunity to Join Boston Scientific Corporation Fraud Investigation with the Schall Law Firm - ChartMill
BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - TMX Newsfile
A Look At Boston Scientific (BSX) Valuation After Class Actions And Electrophysiology Guidance Cuts - simplywall.st
Orion Porfolio Solutions LLC Boosts Position in Boston Scientific Corporation $BSX - MarketBeat
Dynamic Technology Lab Private Ltd Purchases Shares of 24,096 Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Bought by Aptus Capital Advisors LLC - MarketBeat
Boston Scientific Recall And Lawsuits Test Earnings Power And Capital Plans - Yahoo Finance
Is Boston Scientific (BSX) Balancing Buybacks and Litigation or Masking Deeper Electrophysiology Risks? - Yahoo Finance
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Boston Scientific Faces Class Action Lawsuit - Intellectia AI
Boston Scientific Investor Sues Over Growth Projections - Law360
Boston Scientific Overpromised Segment’s Performance, Suit Says - Bloomberg Law News
BSX Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Boston Scientific Corporation – Company AnnouncementFT.com - Financial Times
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX) - marketscreener.com
Rosen Law Firm Urges Boston Scientific Corporation (NYSE: BSX) Stockholders to Contact the Firm for Information About Their Rights - ChartMill
Boston Scientific’s ENTRUST Registry Targets Real-World Edge in Carotid Stroke Prevention - TipRanks
Why Is Boston Scientific (BSX) Down 6% Since Last Earnings Report? - Yahoo Finance
Here's Why Boston Scientific (BSX) is a Strong Growth Stock - Yahoo Finance
Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology - Finviz
Boston Scientific to explain new ACC heart data to investors - Stock Titan
Investor Notice: Robbins LLP Informs Investors of the Boston Scientific Corporation Class Action Lawsuit - The AI Journal
Boston Scientific (BSX) Advances While Market Declines: Some Information for Investors - Yahoo Finance
3 Reasons Boston Scientific Stock Could Quietly 5X as the World Ages - Yahoo Finance
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.29%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):